IFP Advisors’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35 | Buy |
+31
| New | +$35 | ﹤0.01% | 4820 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3340 |
|
|
2021
Q2 | – | Sell |
-3,258
| Closed | -$115K | – | 3052 |
|
|
2021
Q1 | $115K | Hold |
3,258
| – | – | ﹤0.01% | 1106 |
|
|
2020
Q4 | $82K | Hold |
3,258
| – | – | ﹤0.01% | 1221 |
|
|
2020
Q3 | $123K | Hold |
3,258
| – | – | 0.01% | 895 |
|
|
2020
Q2 | $136K | Hold |
3,258
| – | – | 0.01% | 803 |
|
|
2020
Q1 | $67K | Hold |
3,258
| – | – | 0.01% | 988 |
|
|
2019
Q4 | $87K | Hold |
3,258
| – | – | 0.01% | 1012 |
|
|
2019
Q3 | $89K | Buy |
+3,258
| New | +$89K | 0.01% | 1115 |
|
|
2019
Q1 | $115K | Buy |
+4,033
| New | +$115K | 0.02% | 643 |
|
|
2016
Q2 | – | Sell |
-4,033
| Closed | -$115K | – | 3808 |
|
|
2016
Q1 | $115K | Buy |
+4,033
| New | +$115K | 0.02% | 643 |
|